The spirooxindole-pyrrolothiazole heterocyclic hybrids are compounds having the formula:
wherein R is hydrogen and R′ is fluorine (compound 6a) or R is fluorine and R′ is hydrogen (compound 6b). The hybrids may be obtained using a chemical synthesis process involving 1,3-dipolar cycloaddition of 3,5-bis(4/2-fluoro-benzylidene) piperidin-4-ones with isatin and 4-thiazolidinecarboxylic acid in a suitable solvent, preferably 1-butyl-3-methyl-imidazolium bromide (“[bmim]Br”), and preferably under microwave irradiation. Both of these new hybrids demonstrate antimicrobial activity against both gram positive and gram negative drug resistant and non-resistant bacterial pathogens, although compound 6a exhibits more potent antibacterial activity than compound 6b.
螺环氧
吲哚-
吡咯噻唑杂环混合物是具有以下
化学式的化合物:其中R为氢,R′为
氟(化合物6a),或者R为
氟,R′为氢(化合物6b)。这些杂合物可以通过
化学合成过程获得,涉及3,5-双(4/2-
氟苄亚甲基)
哌啶-4-酮与
吲哚酮和4-
噻唑烷
羧酸进行1,3-偶极环加成,在适当溶剂中,最好是1-丁基-3-甲基-
咪唑溴化物(“[bmim]Br”),并最好在微波辐射下进行。这两种新的杂合物对革兰氏阳性和革兰氏阴性耐药和非耐药细菌病原体均表现出抗菌活性,尽管化合物6a表现出比化合物6b更强的抗菌活性。